title: Applying a hypoxia-incorporating TCP model to experimental data on rat sarcoma.
abstract: OBJECTIVE
  To verify whether a tumor control probability (TCP) model which mechanistically incorporates acute and chronic hypoxia is able to describe animal in vivo dose-response data, exhibiting tumor reoxygenation.
  
  
  METHODS
  The investigated TCP model accounts for tumor repopulation, reoxygenation of chronic hypoxia, and fluctuating oxygenation of acute hypoxia. Using the maximum likelihood method, the model is fitted to Fischer-Moulder data on Wag/Rij rats, inoculated with rat rhabdomyosarcoma BA1112, and irradiated in vivo using different fractionation schemes. This data set is chosen because two of the experimental dose-response curves exhibit an inverse dose behavior, which is interpreted as due to reoxygenation. The tested TCP model is complex, and therefore, in vivo cell survival data on the same BA1112 cell line from Reinhold were added to Fischer-Moulder data and fitted simultaneously with a corresponding cell survival function.
  
  
  RESULTS
  The obtained fit to the combined Fischer-Moulder-Reinhold data was statistically acceptable. The best-fit values of the model parameters for which information exists were in the range of published values. The cell survival curves of well-oxygenated and hypoxic cells, computed using the best-fit values of the radiosensitivities and the initial number of clonogens, were in good agreement with the corresponding in vitro and in situ experiments of Reinhold. The best-fit values of most of the hypoxia-related parameters were used to recompute the TCP for non-small cell lung cancer patients as a function of the number of fractions, TCP(n).
  
  
  CONCLUSIONS
  The investigated TCP model adequately describes animal in vivo data exhibiting tumor reoxygenation. The TCP(n) curve computed for non-small cell lung cancer patients with the best-fit values of most of the hypoxia-related parameters confirms previously obtained abrupt reduction in TCP for n < 10, thus warning against the adoption of severely hypofractionated schedules.
authors.affiliation: Department of Radiation Oncology, S. Cuore-don Calabria Hospital, Negrar (VR), Italy. ruggieri.ruggero@gmail.com
authors.forename: Ruggero
authors.initials: R
authors.lastname: Ruggieri
authors.forename: Nadejda
authors.initials: N
authors.lastname: Stavreva
authors.forename: Stefania
authors.initials: S
authors.lastname: Naccarato
authors.forename: Pavel
authors.initials: P
authors.lastname: Stavrev
mesh_terms: D000818:Animals; D015687:Cell Hypoxia / Q000502:physiology*; D045744:Cell Line, Tumor; D002470:Cell Survival; D004307:Dose-Response Relationship, Radiation; D016013:Likelihood Functions; D008954:Models, Biological; D015233:Models, Statistical; D010101:Oxygen Consumption / Q000502:physiology*; D051381:Rats; D011919:Rats, Inbred Strains; D012208:Rhabdomyosarcoma / Q000378:metabolism* / Q000473:pathology / Q000532:radiotherapy